While gabapentin can be effective for improving sleep quality in some individuals, it’s essential to recognize that using this medication may also introduce certain risks. Many patients report experiencing side effects such as dizziness, drowsiness, and impaired coordination. Gabapentin is a prescription medication that’s FDA approved to treat a certain type of seizure and nerve pain from shingles. It’s often used “off-label” for a wide range of conditions, including anxiety, hot flashes, and sleep. Some research shows gabapentin may be effective for sleep. New research on genetically altered mice helps to untangle the complex interactions of GABA with brain systems necessary for sustaining wakefulness. Nerve cells (also known as neurons) in a specific part of the brain, called the tuberomammilary nucleus or TMN, produce histamine. Polysomnography showed no sleep disruptors, 8 hours of sleep, and some delayed slow wave sleep periods. Mean sleep latency testing (MSLT) showed MSL of 15.4min; 1 SOREM (nap #1). With a working diagnosis of hypersomnia due to medical condition vs. idiopathic hypersomnia, methylphenidate up to 36mg ER was trialed with some improvement. GABA‐A antagonists have been used in patients with idiopathic hypersomnia based on the finding of a positive allosteric modulator of GABA‐A receptors within the cerebrospinal fluid of hypersomnolent patients (Rye 2012) and the known sleep‐promoting effects of the GABA‐A system (Lu 2006). One small, open-label clinical study evaluated gabapentin in participants with insomnia as defined by complaints of difficulty initiating and/or maintaining sleep for more than 3 months. Gabapentin significantly improved sleep efficiency, decreased wake after sleep onset (WASO), and increased slow wave sleep relative to baseline. 20 The ICSD-2 (International Classification of Sleep Disorders) terms this disorder "primary hypersomnia" and the proposed DSM-V describes it as "major hypersomnolence disorder." Its prevalence is unclear. The Emory team’s findings could potentially provide a biological definition and a treatment for an under-recognized sleep disorder. Treatment. Idiopathic hypersomnia treatment can help ease symptoms. A common medicine prescribed is the stimulant modafinil (Provigil). This medicine can help you stay awake during the day. Here, we report a case of recurrent hypersomnia in which gabapentin was effective for the prevention of attacks. We speculate that the recurrent hypersomnia and behaviour disturbance are related to epilepsy-like neuronal discharge from the thalamus due to dysfunction in GABAnergic receptors. Gabapentin is an excellent example of a drug that uses this mechanism to blunt the norepinephrine/epinephrine stress response at the level of the adrenal gland. Gabapentin was designed to mimic GABA while not binding to GABA receptors, and is commonly used for neuropathic pain and epilepsy. Rocamora R, Gil-Nagel A, Franch O, Vela-Bueno A. Familial recurrent hypersomnia: two siblings with Kleine-Levin syndrome and menstrual-related hypersomnia. J Child Neurol. 2010 Nov. 25 (11):1408-10. [QxMD MEDLINE Link]. Sachs C, Persson HE, Hagenfeldt K. Menstruation-related periodic hypersomnia: a case study with successful treatment. Gabapentin is a compound widely used in the treatment of epilepsy9 and neuropathic pain.10,11 A number of studies, in both patients and normal subjects, have shown an increase in SWS, decreased number of awakenings, and increased sleep efficien-cy with this drug.12-14 Gabapentin may therefore be an entirely Compare the effectiveness of gabapentin vs. regular sleeping pattern for hypersomnia based on the experiences of 37 members of the hypersomnia research community. Gabapentin is an anticonvulsant with pain-relieving effects that may be used to treat certain seizure disorders or relieve nerve pain. Common side effects include dizziness or drowsiness and it may View more. Prescription only. Prescribed for Idiopathic Hypersomnia, Narcolepsy, Cataplexy, Fibromyalgia. Idiopathic hypersomnia (IH) is a poorly characterized orphan central disorder of hypersomnolence responsible for excessive daytime sleepiness (EDS), prolonged nighttime sleep and sleep inertia that often require long-term symptomatic stimulant medication. To date, no drug has currently the authoriza The second part of this two-part video series focuses on how GABA inhibits neurons, and how research by Dr. Rye and his colleagues at Emory have identified an endogenous molecule in the cerebrospinal fluids of patients with hypersomnia that increases the activity of GABA receptors. Child 6–11 years 10 mg/kg once daily (max. per dose 300 mg) on day 1, then 10 mg/kg twice daily (max. per dose 300 mg) on day 2, then 10 mg/kg 3 times a day (max. per dose 300 mg) on day 3; usual dose 25–35 mg/kg daily in 3 divided doses, some children may not tolerate daily increments; longer intervals (up to weekly) may be more appropriate, daily dose maximum to be given in 3 divided Gabapentin Enacarbil (GEn) or XP13512 is a prodrug of gabapentin, used as an anticonvulsant and for pain relief in postherpetic neuralgia. This new formulation of gabapentin was designed for increased oral bioavailability over gabapentin. The ICSD-2 (International Classification of Sleep Disorders) terms this disorder "primary hypersomnia" and the proposed DSM-V describes it as "major hypersomnolence disorder." Its prevalence is unclear. The Emory team’s findings could potentially provide a biological definition and a treatment for an under-recognized sleep disorder. Gabapentin, an α 2 δ subunit ligand of L-type voltage-gated calcium channels, is indicated for the management of postherpetic neuralgia and restless legs syndrome, and as adjunctive therapy for partial seizures with and without secondary generalization (maximal dose: 600-1800 mg/day depending on indication and gabapentin formulation). 8 –10
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |